Portfolio company
CellFE
United States · £17.4m raised
Raised
£17.4m
Latest stage
Series A
Rounds recorded
1
Backed by
3 investors
Sectors
About
The company develops microfluidic platforms for intracellular delivery of molecules to support cell therapy developers and researchers in manufacturing engineered cells.
SourceFunding history · 1
Similar companies
Indee Labs
Indee Labs develops microfluidic cell engineering instruments for pharmaceutical and biotechnology companies to deliver gene-editing materials into immune cells for therapeutic development.
Transforming cells into cures
This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.
Kytopen
This company develops non-viral gene delivery platforms for biotechnology researchers and pharmaceutical manufacturers to accelerate the production of gene-modified cell therapies.
Trince
This company develops laser-based intracellular delivery technology for biopharmaceutical companies and research institutions to facilitate drug discovery and cell therapy development.
MFX
This company develops automated microfluidic bioreactor platforms and data generation infrastructure for researchers and manufacturers in the cell and gene therapy sector.
Lightcast Bio
This company develops a microfluidic platform for single-cell functional analysis for pharmaceutical companies and academic research institutions.
Cellular Origins
The company develops an automated robotic platform for cell therapy developers to manufacture and scale autologous and allogeneic therapies.
Cellino
The company develops an autonomous biomanufacturing platform to produce personalised stem cell therapies for patients with chronic degenerative diseases.
